Assessment of proliferative activity of thyroid HĂźrthle cell tumors using PCNA, Ki-67 and AgNOR methods. by Augustynowicz, Albert et al.
FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 42, No. 3, 2004
pp. 165-168
Assessment of proliferative activity of thyroid Hürthle
cell tumors using PCNA, Ki-67 and AgNOR methods
Albert Augustynowicz1, Janusz Dzie˛cioł2, Małgorzata Barwijuk-Machała3, 
Jacek Dadan4, Zbigniew Puchalski4 and Stanisław Sulkowski3
1Department of Medical Pathomorphology, 2Department of Anatomy, 3Department of General
Pathomorphology, and 41st Clinic of Surgery, Medical University, Białystok; Poland
Abstract: We have undertaken an attempt to compare the application efficacy of the proliferative activity markers in differential
diagnosis of thyroid Hürthle cell tumors (HCT) using the PCNA and Ki-67 labeling and AgNOR visualisation techniques. The
present work is a retrospective analysis of 78 Hürthle cell tumors: 20 Hürthle cell carcinomas (HCC), 32 Hürthle cell adenomas
(HCA) and 26 hyperplastic nodules with Hürthle cell metaplasia (HCM). Five µm sections were stained according to AgNOR
technique and labeled with antibodies against PCNA and Ki-67. AgNOR dot count in the nucleus and proliferative index (PI
- percentage of cells expressing PCNA and Ki-67) in randomly chosen nuclei (100 in case of AgNOR and over 1000 in case
of PI) were evaluated in each slide. The mean values of AgNOR dot count, PI-PCNA and PI-Ki-67 in HCC, HCA and HCM
were respectively: 5.1, 61.3 and 54.9; 3.4, 42.4 and 38.6 and 2.5, 39.3 and 34.3. Statistically significant difference was found
in all the proliferative activity markers between malignant and benign tumors: HCC:HCA (p<0.01) and HCC:HCM (p<0.001).
There was no statistically significant difference between HCA and HCM.
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Introduction
Lack of cytological features of malignancy makes dif-
ferential diagnosis of follicular tumors of the thyroid
difficult. The only diagnostic criterion is the presence of
vascular or capsular invasion [6]. Reports on the surpris-
ingly unfavourable clinical course of changes identified
as adenomas provide strong evidence of difficulties
encountered in the subjective evaluation of histological
features of malignancy [4]. Hürthle cell tumors, a variant
of follicular tumors, also referred to as oxyphilic tumors,
which are composed of follicular cells with massive
eosinophilic cytoplasm and whose origin has not been
fully elucidated, are considered by many pathologists to
have unpredictable clinical course and to be more ag-
gressive compared to the other well differentiated fol-
licular tumors of the thyroid. The oxyphilic tumors can
be subdivided into oxyphilic carcinoma (Hürthle cell
carcinoma - HCC), oxyphilic adenoma (Hürthle cell
adenoma - HCA) and hyperplastic nodules with oxy-
philic metaplasia (Hürthle cell metaplasia - HCM). Diffi-
culties in the evaluation of their behavior, malignancy
and prognosis have prompted the search for methods
which could be useful in diagnostics. Assessment of the
proliferative activity markers based on immunohisto-
chemical technique using antibodies against PCNA and
Ki-67 is, according to many authors, valuable in the
evaluation of malignancy of many neoplastic lesions [2].
Similar opinions refer to the possible use of the histo-
chemical technique of Ploton et al. [9], based on the
quantitative assessment of argyrophilic nuclear organizer
regions (AgNORs) [10]. Although the reliability of both
techniques seems to be commonly accepted, there are some
controversial opinions concerning their value. Therefore
we decided to compare the efficacy of these proliferative
activity markers by using them in the same study group.
Hürthle cell tumors, being a real diagnostic challenge in
the pathologist’s practice, were chosen as the object of the
study. We hope that the data obtained will appear helpful
in differential diagnosis of nodular oxyphilic lesions.
Materials and methods
The study was carried out on 78 follicular tumors of the thyroid,
diagnosed at the Department of Clinical Pathology, Medical Univer-
sity of Białystok in the years 1990-2003. Among 78 nodular lesions,
there were 20 HCC, 32 HCA and 26 hyperplastic HCM nodules.
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Three sections 5 µm thick were made from each paraffin block
routinely obtained following fixation in 10% buffered formalin.
Staining was performed both by the one-step colloid silver impreg-
nation method described by Ploton et al. [9] and using antibodies
against PCNA (DAKO; monoclonal mouse, clone PC10 at a dilution
1:100) and Ki-67 (DAKO; monoclonal mouse, clone MIB-1 at the
dilution 1:50) with EnVision TM (DAKO) detection kit.
The evaluation of the mean number of AgNOR dots per nucleus
and the proliferative index (PI - the percentage of PCNA- and
Ki-67-positive cells) was performed using two different methods. In
order to assess the mean number of AgNOR dots per nucleus, 100
randomly selected cell nuclei were evaluated in each slide by two
independent observers using Eclipse E 200 microscope at a magni-
fication of × 1000, on the focusing plane with the highest number of
distinctly contrasted argyrophilic granules. PI was determined using
Lucia morphometric program, Minitron video camera and Eclipse E
200 microscope at a magnification of × 400 in ten randomly selected
fields in each slide. The number of all cells per estimated field was
automatically determined and the number of positively stained cell
nuclei was counted semiautomatically after interactive pointing out.
U-Mann-Whitney test was used for statistical analysis. The dif-
ference was considered significant for p<0.05.
Results
The tumors analysed in our study were composed of
cells with eosinophilic cytoplasm, the so called
Hürthle cells (Fig. 1). The diagnosis of tumor malig-
nancy, confirmed by two pathologists, was based on
the presence of capsular or vascular invasion, while
the presence of the capsule and normal or com-
pressed tissue around the tumor was required to
diagnose adenoma and to exclude hyperplastic cell
tumors with oxyphilic metaplasia [6]. The specific
granular, nuclear staining was present in cells with
overexpression of PCNA or Ki-67. The thyroid
tissue demonstrated diffuse, nonspecific, weak cyto-
plasmic reaction (Fig. 2a,b). The one-step silver col-
loid staining visualizated the AgNORs as dark dots
within cell nuclei (Fig. 2c). 
The values of PCNA PI and Ki-67 PI as well as the
mean AgNOR counts in nuclei of Hürthle cell carcinomas,
Hürthle cell adenomas and hyperplastic nodules with
Hürthle cell metaplasia are presented in Table 1. They were
the highest in malignant tumors and the lowest in non-neo-
plastic oxyphilic metaplasia. The values of PI were some-
what higher in the case of PCNA compared to Ki-67.
Similar statistically significant differences were noticed for
all methods used in our study between malignant and
benign tumors: HCC:HCA (p<0.01) and HCC:HCM
(p<0.001). Irrespective of the proliferative activity mar-
ker examined, no statistically significant difference was
found between oxyphilic adenoma and oxyphilic meta-
plasia. Non-diagnostic overlapping values between the
groups were observed for all the methods.
Discussion
It has been known for a long time that the more
frequent division figures are found in the microscopic
image of a tumor, the more aggressive is tumor beha-
vior. No wonder that attempts have been made to
assess the proliferative activity of tumors in the rou-
tine differential diagnosis of changes which are diffi-
cult to discriminate. Widely applied methods using
routinely obtained paraffin blocks are based either on
cheap and easily accessible immunohistochemical
techniques evaluating the expression of PCNA and
Ki-67 proliferation markers or on the histochemical
AgNOR silver impregnation technique. These meth-
ods are commonly referred to as the markers of pro-
liferative activity, and show a good correlation with
precise research techniques used to assess the mitotic
activity [2, 10, 12]. Are they exchangeable or univer-
sal? Can one of them be regarded as the best or the
most convenient? We tried to find in our study the
most precise marker of the proliferative activity of
thyroid oxyphilic tumors. 
Our results are consistent with the data concerning
follicular tumors, particularly oxyphilic tumors of the
thyroid. Most authors report that the expression of
PCNA and Ki-67, and AgNOR count assessed in malig-
nant and benign tumors of that type differ significantly
[1, 2, 7, 10, 11, 12]. However, there are differences in
the absolute values of PI obtained by immunohisto-
chemical analysis in our own study compared to the
literature data. Generally, the PI-PCNA and PI-Ki-67
values reported in the literature are lower: the mean
index for PCNA was 6.6 in HCA, 19.1 in indeterminate
HCT and 24.54 in HCC [11], and the respective values
for Ki-67 were 10.0 in HCC, 3.2 in HCA and 5.0 in UMB
(uncertain malignant behavior) [3]. The mean AgNOR
counts in the nuclei according to the literature data are
close to those obtained in our study, ranging from 5.8 to
4.5 for HCC and from 3.9 to 3.0 for HCA, although some
authors did not find significant differences between
Table 1. Proliferative activity markers in Hürthle cell tumors
PCNA PI Ki-67 PI AgNOR count
Hürthle cell carcinoma 61.3 (72.1-49.8)1,2 54.9 (58.5-44.2) 1,2 5.1 (6.7-3.5) 1,2
Hürthle cell adenoma 42.4 (56.3-34.2) 38.6 (48.1-30.0) 3.4 (4.1-2.2)
Hürthle cell metaplasia 39.3 (52.8-31.3) 34.3 (45.7-29.4) 2.5 (3.3-2.0)
1
- with HCA (p<0.01); 2- with HCM (p<0.001); PI-proliferative index
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these groups [1]. No literature data are available on the
proliferative activity of HCM. 
A more detailed analysis and comparison of the
obtained results with the literature data encounter
serious difficulties, because of different methods of
quantitative analysis and various ways of tumor
grouping. Determination of the proliferative index also
differs among the investigators. The PI can be calculated
as the percentage of positive cells per 100 evaluated cells
or per different number of cells. It can also be assessed
by the number of positively stained cells per the number
of fields examined (High Power Field - HPF). It is
Fig. 1. Histological structure of Hürthle cell tumors: HCC (a), HCA (b) and HCM (c). H-E. × 400. Fig. 2. Proliferative activity markers
examined in Hürthle cell tumors: PCNA (a), Ki-67 (b) and AgNORs (c). a, b - × 400; c - × 1000.
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impossible to compare Ki-67 expression presented
as 12/10HPF in oxyphilic adenoma and 76/10HPF in
carcinoma [8] with the values obtained in our study.
The observed discrepancies are also due to differen-
ces in division of tumors into groups. The most
common is a division into benign and malignant
tumors, i.e. carcinomas and adenomas, although a
division into benign, suspected of malignancy and
malignant tumors or benign, indeterminate, sus-
pected of malignancy and malignant ones is also
frequently used. Malignant carcinomas can still be
subdivided into encapsulated, slightly infiltrative
and extensively infiltrative, sometimes with vascular
invasion. It happens that authors combine histologi-
cally different groups, which practically precludes
comparison, e.g. in the study of Horii et al. [5], the
values of Ki-67 were 39.9 and 9.4 for TCA (thyroid
carcinoma) and TA (thyroid adenoma), respectively.
Quite confusing is also the "score" system used in the
study of Czyz˙ et al. [2] to estimate the percentage of
cases in which the number of PCNA-positive cells
exceeds 5% (shown in 47% of carcinomas and 64% of
adenomas). It seems that there are no standard meth-
ods to quantitatively estimate the proliferative activity
of HCTs. 
Irrespective of the correlation between our results
and the literature data, it can be concluded that in the
case of oxyphilic tumors of the thyroid divided into
HCCA, HCA and HCM, the PCNA PI, Ki-67 PI and
AgNOR count used as markers in the present study
similarly reflect differences between the proliferative
activity of the groups. According to most authors,
however, the occurrence of non-diagnostic overlap-
ping value intervals between the groups makes deter-
mination of these parameters only an adjunct to the
differential diagnostics of malignant and benign oxy-
philic tumors of the thyroid. 
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